Is It Still Worth Buying GSK After a 46% Rally in Shares This Year
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
This analysis points to fund families that consistently stood out in index fund history, helping you recognize dominant players over time.
25,021 articlesGSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
One year after the pledge, the Strategic Petroleum Reserve remains short of full capacity while crude prices push pas...
The FAA has halted all JetBlue flights at the airline’s request, triggering widespread travel disruption and a swift ...
New Jersey Realtors is pressing lawmakers to reform or repeal the Graduated Percent Fee on residential sales, arguing...
What to expect from Kodiak’s 2025 earnings? This guide breaks down revenue drivers, margins, and realistic scenarios ...
IonQ posted full-year revenue of $130 million and a 2026 guidance of $225-245 million, as it leans on defense contrac...
Uber expands its autonomous-vehicle ambitions by teaming up with Zoox, clouding the landscape with more AV partners a...
UiPath shares fell about 6% after a strong earnings print, prompting analysts to debate whether the AI automation the...
Reno has overtaken Las Vegas as the top destination for California homebuyers seeking affordability, driven by supply...
Thrivent plans to hire 600 financial advisors in 2026, a move that bucks the AI-driven layoff trend and expands acces...
Pi Network’s PI token fell about 30% within 24 hours after Kraken’s listing, renewing questions about the project’s r...
A bold investing thesis centers on a single nuclear stock with big plans for small modular reactors and recycled fuel...